新型原蛋白膜配方,含有 irinotekan 或minocycline,可用于大脑癌症的潜在应用
Andreea-Anamaria Idu1,2, Mădălina Georgiana Albu Kaya3, Ileana Rău1
1Department of General Chemistry, Faculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, 011061 Bucharest, Romania.
Materials (Basel, Switzerland)
|July 27, 2024
概括
装有米诺环素或 irinotcan 的原膜为质母细胞瘤治疗提供了一个有前途的局部药物递送系统,减少副作用并改善瘤部位的药物度.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 组织工程是组织工程.
背景情况:
- 系统化疗面临诸如血脑屏障等挑战,限制了质母细胞瘤的疗效.
- 局部药物输送提高了生物可用性,降低了全身毒性.
- 原膜为控制药物释放提供了一个生物相容的平台.
研究的目的:
- 开发和表征与米诺环素或氨基酸结合的原膜.
- 评估这些膜在质母细胞瘤治疗中用于局部药物输送的潜力.
- 为了突出比系统管理的优势.
主要方法:
- 提取I型原蛋白并与甲交叉连接以形成膜.
- 纳入米诺环素 (抗生素) 和氨酸 (化疗) 在不同度.
- 通过吸水和酶降解试验评估膜性质.
主要成果:
- 开发的原膜与集成的米诺环素或氨基酸.
- 经过证明的膜透性适合药物释放.
- 展示了局部和持续药物输送的潜力.
结论:
- 原膜是局部药物输送的可行策略,特别是在高度质瘤中.
- 这种方法提高了药物的生物可用性,并最大限度地减少了系统性不良影响.
- 在质母细胞瘤治疗结果方面提供了显著的进步.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.